General Information of Drug (ID: DMBLID9)

Drug Name
N-acetylcysteine Drug Info
Synonyms
N-Acetyl-L-cysteine; acetylcysteine; 616-91-1; N-Acetylcysteine; mercapturic acid; Acetadote; L-Acetylcysteine; Broncholysin; Fluimucil; Mucomyst; N-Acetyl-cysteine; Parvolex; Fluprowit; Acetein; Airbron; Fabrol; Flumucetin; Mucosolvin; Fluimucetin; Mucosil; Brunac; Fluimicil Infantil; Acetylcysteinum; Acetilcisteina; Respaire; Mucofilin; Lysomucil; Exomuc; Inspir; Ac-Cys-OH; Mucolyticum Lappe; Mucolytikum Lappe; N-Acetyl cysteine; Mucolyticum; LNAC; N-Acetyl-3-mercaptoalanine; N-Acetyl-L-(+)-cysteine; Neo-fluimucil; NAC-TB; Mucolyticum-Lappe; (R; Acetylcysteine
Cross-matching ID
PubChem CID
12035
ChEBI ID
CHEMBL600
CAS Number
CAS 616-91-1
TTD Drug ID
D05NEK

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
DNA replication 2.14 0.00e+0 34/36 (94.44%) PCNA;RFC3;POLE2;...
Autoimmune thyroid disease 2.02 2.90e-3 46/53 (86.79%) HLA-DPA1;CD86;HLA-C;...
Allograft rejection 1.95 3.87e-3 32/38 (84.21%) HLA-DPA1;CD86;HLA-C;...
RNA polymerase 1.84 1.45e-2 23/31 (74.19%) POLR3K;POLR3G;POLR1D;...
Nucleotide excision repair 1.83 1.39e-2 40/47 (85.11%) RAD23B;PCNA;RFC3;...
Pyrimidine metabolism 1.79 1.93e-2 40/56 (71.43%) ENTPD1;DTYMK;RRM2;...
Graft-versus-host disease 1.76 2.07e-2 32/42 (76.19%) HLA-DPA1;CD86;HLA-C;...
Base excision repair 1.73 2.32e-2 29/33 (87.88%) PCNA;POLE2;FEN1;...
Mismatch repair 1.72 2.26e-2 22/23 (95.65%) PCNA;RFC3;MLH3;...
Cell cycle 1.71 2.09e-2 110/124 (88.71%) CCNB1;CDKN1B;PCNA;...
Antigen processing and presentation 1.70 2.22e-2 60/78 (76.92%) HLA-DPA1;IFI30;HLA-C;...
Fanconi anemia pathway 1.62 4.64e-2 36/54 (66.67%) RAD51C;FANCG;FANCL;...
Homologous recombination 1.60 4.95e-2 35/41 (85.37%) RAD51C;RPA3;POLD3;...
Pertussis -1.73 4.25e-2 64/76 (84.21%) NLRP3;CALML4;IRF3;...
Kaposi sarcoma-associated herpesvirus infection -1.80 2.69e-2 172/193 (89.12%) PDGFB;LEF1;CCR5;...
Glycerolipid metabolism -1.82 2.21e-2 44/61 (72.13%) LPIN2;TKFC;AGPAT3;...
Rheumatoid arthritis -1.84 1.24e-2 78/93 (83.87%) ATP6V1H;TGFB3;ATP6V0B;...
Lipid and atherosclerosis -1.87 8.10e-3 190/215 (88.37%) MAP2K6;TBK1;BID;...
Amoebiasis -1.90 9.45e-3 99/102 (97.06%) IL1B;RELA;PLCB2;...
Nicotinate and nicotinamide metabolism -1.93 8.51e-3 25/35 (71.43%) SIRT1;NADK;NT5C;...
NF-kappa B signaling pathway -1.94 7.09e-3 90/104 (86.54%) CSNK2B;CARD14;IRAK1;...
Legionellosis -2.01 0.00e+0 51/57 (89.47%) C3;SAR1A;CASP9;...
TNF signaling pathway -2.24 0.00e+0 103/112 (91.96%) MAP2K6;BCL3;DNM1L;...
IL-17 signaling pathway -2.35 0.00e+0 84/94 (89.36%) TAB2;IL1B;RELA;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Breast
Breast adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF7 CVCL_0031 Homo sapiens 0.002uM - 10uM 6H, 24H
MDA-MB-231 CVCL_0062 Homo sapiens 0.01uM - 10uM 24H
Breast epithelium
Normal
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF-10A CVCL_0598 Homo sapiens 0.01uM - 10uM 24H
Cervix
Cervical adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HeLa CVCL_0030 Homo sapiens 0.01uM - 10uM 24H
Colon
Colorectal adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HT-29 CVCL_0320 Homo sapiens 0.01uM - 10uM 24H
Kidney
Normal (Immortalized)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HA1E CVCL_0284 Homo sapiens 0.01uM - 10uM 24H
Normal (Transformed)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HEK293 CVCL_0045 Homo sapiens 0.01uM - 10uM 24H
Lung
Lung adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A549 CVCL_0023 Homo sapiens 0.002uM - 10uM 6H, 24H
Non-small cell lung carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HCC515 CVCL_5134 Homo sapiens 0.002uM - 10uM 6H
Pancreas
Pancreatic carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
YAPC CVCL_1791 Homo sapiens 0.01uM - 10uM 24H
Peripheral blood
Acute monocytic leukemia
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
THP-1 CVCL_0006 Homo sapiens 0.01uM - 10uM 24H
T-cell acute lymphoblastic leukemia
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
Jurkat CVCL_0367 Homo sapiens 0.01uM - 10uM 24H
Prostate
Prostate carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
PC-3 CVCL_0035 Homo sapiens 0.002uM - 10uM 6H, 24H
Skin
Melanoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A-375 CVCL_0132 Homo sapiens 0.01uM - 10uM 24H